We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $151M
1-Year Est. Return 76.14%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+76.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$25.1M
Cap. Flow
+$25M
Cap. Flow %
16.54%
Top 10 Hldgs %
81.2%
Holding
96
New
30
Increased
14
Reduced
23
Closed
27

Top Buys

1
INVA icon
Innoviva
INVA
+$2.52M
2
QNRX
Quoin Pharmaceuticals
QNRX
+$1.78M
3
TOI icon
The Oncology Institute
TOI
+$1.42M
4
PPC icon
Pilgrim's Pride
PPC
+$1.27M
5
CALM icon
Cal-Maine
CALM
+$1.17M

Top Sells

1
AGRO icon
Adecoagro
AGRO
+$1.68M
2
RTAC
Renatus Tactical Acquisition Corp I
RTAC
+$937K
3
JBS
JBS N.V.
JBS
+$934K
4
EWY icon
iShares MSCI South Korea ETF
EWY
+$919K
5
OKYO
OKYO Pharma
OKYO
+$908K

Sector Composition

1 Healthcare 14.59%
2 Consumer Staples 4.5%
3 Real Estate 1.4%
4 Energy 1.15%
5 Financials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$6.52B
$570K 0.38%
8,362
+3,600
+76% +$255K
ESTA icon
27
Establishment Labs
ESTA
$2.72B
$535K 0.35%
9,428
-3,067
-25% -$209K
UTI icon
28
Universal Technical Institute
UTI
$2.22B
$526K 0.35%
14,581
-3,341
-19% -$105K
COUR icon
29
Coursera
COUR
$1.59B
$513K 0.34%
88,172
+75,570
+600% +$472K
CPA icon
30
Copa Holdings
CPA
$5.67B
$489K 0.32%
+4,304
New +$565K
DOLE icon
31
Dole
DOLE
$1.37B
$472K 0.31%
33,013
-28,047
-46% -$425K
CAPR icon
32
Capricor Therapeutics
CAPR
$1.13B
$428K 0.28%
+14,070
New +$375K
STIM icon
33
Neuronetics
STIM
$113M
$390K 0.26%
269,208
+108,281
+67% +$172K
XP icon
34
XP
XP
$8.61B
$384K 0.25%
20,176
-26,520
-57% -$512K
JBS
35
JBS N.V.
JBS
$39.2B
$383K 0.25%
21,308
-60,011
-74% -$934K
CHRN
36
ChronoScale Holdings
CHRN
$3.84B
$378K 0.25%
+35,493
New +$351K
CRIS icon
37
Curis
CRIS
$9.02M
$362K 0.24%
+32,936
New +$613K
DC icon
38
Dakota Gold
DC
$558M
$349K 0.23%
+69,041
New +$409K
CGTX icon
39
Cognition Therapeutics
CGTX
$86M
$327K 0.22%
431,000
-35,000
-8% -$40.7K
TLPH icon
40
Talphera
TLPH
$68.5M
$325K 0.22%
435,234
-144,086
-25% -$130K
ACIU icon
41
AC Immune
ACIU
$224M
$296K 0.2%
107,489
-8,188
-7% -$25.4K
MPLX icon
42
MPLX
MPLX
$57.9B
$295K 0.2%
+5,170
New +$293K
FUTU icon
43
Futu Holdings
FUTU
$13.3B
$254K 0.17%
+1,854
New +$288K
ET icon
44
Energy Transfer Partners
ET
$69.9B
$237K 0.16%
+12,300
New +$225K
INMB icon
45
INmune Bio
INMB
$50.5M
$207K 0.14%
183,476
-121,446
-40% -$173K
VSTM icon
46
Verastem
VSTM
$530M
$195K 0.13%
+36,750
New +$227K
EPD icon
47
Enterprise Products Partners
EPD
$82.6B
$193K 0.13%
+5,100
New +$181K
VITL icon
48
Vital Farms
VITL
$581M
$164K 0.11%
+11,603
New +$274K
ADAG
49
Adagene
ADAG
$237M
$136K 0.09%
+34,775
New +$101K
CHRS icon
50
Coherus Oncology
CHRS
$216M
$129K 0.09%
+76,087
New +$135K
1
2
3 4

Similar funds

MWS
MFA Wealth Services Thousand Oaks, California $151M AUM 17.08% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $151M AUM 14.38% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BA
Brightwater Advisory Tampa, Florida $151M AUM 17.08% 1-Year Est. Return
HTWM
Hartmann Taylor Wealth Management Dallas, Texas $151M AUM 15.15% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
FWM
Fingerlakes Wealth Management Ithaca, New York $151M AUM 20.78% 1-Year Est. Return

Dauntless Investment Group's Q1 2026 Portfolio in Review

As of Q1 2026, Dauntless Investment Group held 96 positions worth $151M, up 20% from $126M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Dauntless Investment Group deployed $25M of net new capital in Q1 2026, opening 30 new positions and adding to 14 existing holdings. Its largest new stake was Quoin Pharmaceuticals: 196,592 shares worth $1.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 7.9% a quarter earlier, followed by Consumer Staples and Real Estate.

On the sell side, the largest reduction was Adecoagro, an estimated $1.68M trimmed.

  • Dauntless Investment Group's largest Q1 2026 buy was Quoin Pharmaceuticals: 196,592 shares worth $1.3M.
  • Dauntless Investment Group added most to Innoviva in Q1 2026, an estimated $2.52M increase.
  • Dauntless Investment Group's biggest Q1 2026 reduction was Adecoagro, cutting an estimated $1.68M.
  • Dauntless Investment Group fully exited iShares MSCI South Korea ETF in Q1 2026, selling an estimated $919K.
  • Dauntless Investment Group's ten largest holdings make up 81% of its $151M portfolio in Q1 2026.
  • Dauntless Investment Group opened 30 new positions and closed 27 in Q1 2026.
  • Dauntless Investment Group's portfolio value rose 20% quarter-over-quarter to $151M.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.